Table 3.
Association between expression of genes and clinical data (AC: adenocarcinoma, SCC: squamous cell carcinoma).
| SNHG6 up-regulation | SNHG6 down-regulation | P value | SNHG16 up-regulation | SNHG16 Down-regulation | P value | LINC00346 up-regulation | LINC00346 down-regulation | P value | LINC00511 up-regulation | LINC00511 down-regulation | P value | MALAT1 up-regulation | MALAT1 down-regulation | P value | VDR up-regulation | VDR down-regulation | P value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | 0.58 | 0.78 | 0.8 | 0.53 | 0.36 | 0.38 | ||||||||||||
| >60 | 7 (31.8%) | 15 (68.2%) | 9 (40.9%) | 13 (59.1%) | 8 (36.4%) | 14 (63.6%) | 12 (54.5%) | 10 (45.5%) | 13 (59.1%) | 9 (40.9%) | 6 (27.3%) | 16 (72.7%) | ||||||
| ≤60 | 8 (40%) | 12 (60%) | 9 (45%) | 11 (55%) | 8 (40%) | 12 (60%) | 9 (45%) | 11 (55%) | 9 (45%) | 11 (55%) | 8 (40%) | 12 (60%) | ||||||
| Sex | 1 | 0.08 | 0.68 | 0.49 | 0.37 | 0.03 | ||||||||||||
| Female | 11 (36.7%) | 19 (63.3%) | 10 (33.3%) | 20 (66.7%) | 12 (40%) | 18 (60%) | 16 (53.3%) | 14 (46.7%) | 17 (56.7%) | 13 (43.3%) | 5 (23.3%) | 23 (76.7%) | ||||||
| Male | 4 (33.3%) | 8 (66.7%) | 8 (66.7%) | 4 (33.3%) | 4 (33.3%) | 8 (66.7%) | 5 (41.7%) | 7 (58.3%) | 5 (41.7%) | 7 (58.3%) | 7 (58.3%) | 5 (41.7%) | ||||||
| Subtype | 0.3 | 0.85 | 0.58 | 1 | 0.37 | 0.5 | ||||||||||||
| AC | 7 (29.2%) | 17 (70.8%) | 10 (41.7%) | 14 (58.3%) | 10 (41.7%) | 14 (58.3%) | 12 (50%) | 12 (50%) | 14 (58.3%) | 10 (41.7%) | 9 (37.5%) | 15 (62.5%) | ||||||
| SCC | 8 (44.4%) | 10 (55.6%) | 8 (44.4%) | 10 (55.6%) | 6 (33.3%) | 12 (66.7%) | 9 (50%) | 9 (50%) | 8 (44.4%) | 10 (55.6%) | 5 (27.8%) | 13 (72.2%) | ||||||
| Stage | 0.53 | 0.43 | 0.47 | 0.67 | 0.56 | 0.11 | ||||||||||||
| I | 4 (50%) | 4 (50%) | 5 (62.5%) | 3 (37.5%) | 4 (50%) | 4 (50%) | 5 (62.5%) | 3 (37.5%) | 4 (50%) | 4 (50%) | 3 (37.5%) | 5 (62.5%) | ||||||
| II | 6 (37.5%) | 10 (62.5%) | 7 (43.8%) | 9 (56.2%) | 7 (43.8%) | 9 (56.3%) | 7 (43.8%) | 9 (56.3%) | 10 (62.5%) | 6 (37.5%) | 8 (50%) | 8 (50%) | ||||||
| III | 5 (27.8%) | 13 (72.2%) | 6 (33.3%) | 12 (66.7%) | 5 (27.8%) | 13 (72.2%) | 9 (50%) | 9 (50%) | 8 (44.4%) | 10 (55.6%) | 3 (16.7%) | 15 (83.3%) | ||||||
| Smoking | 1 | 0.25 | 1 | 1 | 0.44 | 1 | ||||||||||||
| Yes | 3 (37.5%) | 5 (62.5%) | 5 (62.5%) | 3 (37.5%) | 3 (37.5%) | 5 (62.5%) | 4 (50%) | 4 (50%) | 3 (37.5%) | 5 (62.5%) | 3 (37.5%) | 5 (62.5%) | ||||||
| No | 12 (35.3%) | 22 (64.7%) | 13 (38.2%) | 21 (61.8%) | 13 (38.2%) | 21 (61.8%) | 17 (50%) | 17 (50%) | 19 (55.9%) | 15 (44.1%) | 11 (32.4%) | 23 (67.6%) | ||||||